Home / Recalls / Medical Devices
Accriva Diagnostics, Inc. recalls directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
Recalled June 24, 2026 · FDA recall Z-2460-2026 · Accriva Diagnostics
Hazard
Assayed Whole blood control contains labeling with incorrect performance range. · FDA Class II
Units
6060
Sold at
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MT, NC, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Hong Kong, Spain.
Description
Assayed Whole blood control contains labeling with incorrect performance range.
Product
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
Manufacturer(s)
Accriva Diagnostics, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →